FROM OUR EXPERTS
So what's the deal with Advair and Symbicort? These meds have helped so many asthmatics finally gain control of their asthma, yet, with all the recent warnings, the FDA seems to be wary of these meds, and this is scaring people.
Should we be wary and quit taking them? Or, should we continue to use these meds to control asthma? I personally agree with Dr. Matthew Minz that you should fear not. Allow me to explain.
Both Advair and Symbicort contain a Long Acting Beta Adrenergic (LABA) to keep the air passages in your lungs from spasming. In Advair the LABA is Serevent, in Symbicort the LABA is Formoterol.
Some reports say LABAs are linked to worsening asthma and even death, such as this warning about Advair: "University of Iowa researchers have added their voices to growing warnings about Advair, saying that drugs that use salmeterol in combination with an inhaled corticosteroid can make asthma more severe or even f...
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation. But what many people don't understand is that the steroids that have caused that negative publicity are NOT the kind of steroids that asthma sufferers take. In fact, the steroids that people are fearful of are called anabolic steroids, artificial substances used by some bodybuilders and athletes to build bigger muscles and enhance athletic performance. This type of steroids bears no resemblance to the inhaled steroids you may be taking. Inhaled steroids are actually very similar to natural substances in your own body. Although all medicines can cause side effects, the inhaled steroids used for asthma have proven to be very safe. Most side effects, if they do occur, lessen or even disappear over time. And the benefits greatly outweigh any risks, at any rate. However, other long-term asthma medications that are sometimes...
While the economy sputters, the long acting bronchodilator/ corticosteroid combination inhaler market is booming. While big pharmaceutical companies fight it out to maintain or gain a piece of this pie, we asthmatics should be the beneficiaries.
New drugs, and new marketing ploys, may soon be available in the U.S. market to compete with Advair and Symbicort, which will provide more options for asthmatics like you and me. Plus, as we all know, more competition means lower costs.
Advair and Symbicort are asthma combination inhalers that have both a long acting bronchodilator (LAB) to treat the airway narrowing (bronchospasm) component of asthma, but also a corticosteroid to treat the chronic inflammation side of asthma.
Advair (called Seritide in Europe), which is marketed by GlaxoSmithKline (GSK) out of London, became available in the U.S. in 2001, and presently has the lead in this booming market. Adviar consists of the LAB Salmeterol (Serev...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.